Synergistic effects of lipopolysaccharide and interferon-γ in inducing interleukin-8 production in human monocytic THP-1 cells is accompanied by up-regulation of CD14, toll-like receptor 4, MD-2 and MyD88 expression

Journal of Endotoxin Research

Volumn 9, Issue 3, 2003, Pages 145-153

  Tamai, Riyoko ^a   Sugawara, Shunji ^a   Takeuchi, Osamu ^b   Akira, Shizuo ^b   Takada, Haruhiko ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 8; MESSENGER RNA; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKEMIA CELL LINE; MONOCYTE; MONOCYTIC LEUKEMIA; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; CELL LINE, TUMOR; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALMONELLA ENTERICA; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; UP-REGULATION;

BACTERIA (MICROORGANISMS);

EID: 0038344850     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103125001540     Document Type: Article

References (54)

1. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am 1992; 267: 54-61.
2. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv Immunol 1996; 62: 61-130.
3. De Maeyer E, De Maeyer-Guignard J. Interferons. In: Thomson AW. (ed) The Cytokine Handbook, 3rd edn. London: Academic Press, 1998; 491-516.
4. Sanceau J, Wijdenes J, Revel M, Wietzerbin J. IL-6 and IL-6 receptor modulation by IFN-γ and tumor necrosis factor-α in human monocytic cell line (THP-1): priming effect of IFN-γ. J Immunol 1991; 147: 2630-2637.
5. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenic factor in autoimmunity. Immunol Today 1992; 13: 157-160.
6. Martin CA, Dorf ME. Interleukin-6 production by murine macrophage cell lines P388D1 and J774A.1: stimulation requirements and kinetics. Cell Immunol 1990; 128: 555-568.
7. Sayers TJ, Macher I, Chung J, Kugler E. The production of tumor necrosis factor by mouse bone marrow-derived macrophages in response to bacterial lipopolysaccharide and a chemically synthesized monosaccharide precursor. J Immunol 1987; 138: 2935-2940.
8. Flesch IEA, Hess JH, Huang S et al. Early interleukin-12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J Exp Med 1995; 181: 1615-1621.
9. Gifford GE, Lohmann-Matthes M-L. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst 1987; 78: 121-124.
10. Koerner TJ, Adams DO, Hamiton TA. Regulation of tumor necrosis factor (TNF) expression: interferon-γ enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages. Cell Immunol 1987; 109: 437-443.
11. Arenzana-Seisdedos F, Virelizier JL, Fiers W. Interferons as macrophage-activating factors. III. Preferential effects of interferon-γ on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol 1985; 134: 2444-2448.
12. Hermann P, Rubio M, Nakajima T, Delespesse G, Sarfati M. IFN-α priming of human monocytes differentially regulates Gram-positive and Gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p7O, CD80, and MHC class I expression. J Immunol 1998; 161: 2011-2018.
13. Ma X, Chow JM, Gri G et al. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J Exp Med 1996; 183: 147-157.
14. Mackensen A, Galanos C, Engelhardt R. Modulating activity of interferon-γ on endotoxin-induced cytokine production in cancer patients. Blood 1991; 78: 3254-3258.
15. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787.
16. Means TK, Golenbock DT, Fenton MJ. Structure and function of Toll-like receptor proteins. Life Sci 2000; 68: 241-258.
17. Wright SD, Tobias PS, Ulevitch RJ, Ramos RA. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989; 170: 1231-1241.
18. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
19. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988; 141: 547-552.
20. Frey EA, Miller DS, Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-1671.
21. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
22. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
23. Hoshino K, Takeuchi O, Kawai T et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752.
24. Qureshi ST, Larivière L, Leveque G et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-625.
25. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115-122.
26. Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782.
27. Akashi S, Shimazu R, Ogata H et al. Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000; 164: 3471-3475.
28. Galanos C, Lüderitz O, Westphal O. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentbl Bakteriol Mikrobiol Hyg Abr 1 Orig Reihe A 1979; 243: 226-244.
29. Adachi O, Kawai T, Takeda K et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9: 143-150.
30. Matsushima K, Morishita K, Yoshimura T et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167: 1883-1893.
31. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocytic antigen CD14 is a phospholipid anchored membrane protein. Blood 1989; 73: 284-289.
32. Tokunaga K, Nakamura Y, Sakata K et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47: 5616-5619.
33. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
34. Åbrink M, Gobl AE, Huang R, Nilsson K, Hellman L. Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. Leukemia 1994; 8: 1579-1584.
35. Raponi G, Ghezzi MC, Mancini C. The release of tumor necrosis alpha (TNF-α) by interferon gamma (IFN-γ) induced THP-1 cells stimulated with smooth lipopolysaccharide is inhibited by MAbs against HLA-DR and CD14 receptors on the effector cell. Microbiologica 1997; 20:1-6.
36. Ohmori Y, Hamilton TA. IFN-γ selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J Immunol 1994; 153: 2204-2212.
37. Bauermeister K, Burger M, Almanasreh N et al. Distinct regulation of IL-8 and MCP-1 by LPS and interferon-γ-treated human peritoneal macrophages. Nephrol Dial Transplant 1998; 13: 1412-1419.
38. Horng T, Barton GM, Medzhitov R. TIRAP: an adaptor molecule in the Toll signaling pathway. Nat Immunol 2001; 2: 835-841.
39. Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al. Mal (MyD88-adaptor-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 413: 78-83.
40. Driggers PH, Ennist DL, Gleason SL et al. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1990; 87: 3743-3747.
41. Rehli M, Poltorak A, Schwarzfischer L, Krause SW, Andreesen R, Beutler B. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 2000; 275: 9773-9781.
42. Politis AD, Ozato K, Coligan JE, Vogel SN. Regulation of IFN-γ-induced nuclear expression of IFN consensus sequence binding protein in murine peritoneal macrophages. J Immunol 1994; 152: 2270-2278.
43. Perera P-Y, Mayadas TN, Takeuchi O et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression. J Immunol 2001; 166: 574-581.
44. Harroch S, Gothelf Y, Revel M, Chebath J. 5′-Upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: detection of functional IRF-1 and Stat factors binding sites. Nucleic Acids Res 1995; 23: 3539-3546.
45. Bovolenta C, Driggers PH, Marks MS et al. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci USA 1994; 91: 5046-5050.
46. Politis AD, Sivo J, Driggers PH, Ozato K, Vogel SN. Modulation of interferon consensus sequence binding protein mRNA in murine peritoneal macrophages. J Immunol 1992; 148: 801-807.
47. Sharf R, Azriel A, Lejbkowicz F, Winograd SS, Ehrlich R, Levi B-Z. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J Biol Chem 1995; 270: 13063-13069.
48. Sharf R, Meraro D, Azriel A et al. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem 1997; 272: 9785-9792.
49. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994; 56: 554-558.
50. Murayama T, Mukaida N, Khabar KSA, Matsushima K. Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. J Leukoc Biol 1998; 64: 62-67.
51. Holtmann H, Winzen R, Holland P et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 1999; 19: 6742-6753.
52. + fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD14 and MyD88 mRNA expression. Infect Immun 2002; 70: 1272-1278.
53. Uehara A, Sugawara S, Tamai R, Takada H. Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharides, lipoteichoic acids and peptidoglycans in the presence of soluble CD14. Med Microbiol Immunol 2001; 189: 185-192.
54. Uehara A, Sugawara S, Takada H. Priming of human oral epithelial cells by interferon-γ to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans. J Med Microbiol 2002; 51: 626-634.